封面
市场调查报告书
商品编码
1544632

医疗保健市场中的人工智慧测试、检验和认证(TIC)服务、机会、成长动力、产业趋势分析和预测,2024-2032

AI Testing, Inspection and Certification (TIC) Services in Healthcare Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 300 Pages | 商品交期: 2-3个工作天内

价格
简介目录

随着人工智慧与医疗设备的整合不断增加,医疗保健市场中的人工智慧测试、检验和认证 (TIC) 服务预计从 2024 年到 2032 年将以超过 15% 的复合年增长率成长。

随着创新设备在医疗保健领域首次亮相,TIC 服务对于确保人工智慧驱动的技术遵守严格的安全和效能基准变得至关重要。这些努力不仅推动了医疗保健技术的进步,而且优先考虑了患者的福祉。举个例子,2024 年 6 月,Element Materials Technology 推出了 RegNav,这是其首个专为医疗器材量身订製的人工智慧驱动的监管情报平台,强调 FDA 提高监管效率和安全性的途径。

整个市场分为服务、类型、应用和区域。

根据类型,预计 2024 年至 2032 年,内部医疗保健市场中的 AI TIC 服务将以显着速度增长。组织正在进行彻底的评估,以确认这些技术的准确性、安全性和可靠性,以利用受控环境进行细緻的测试和客製化解决方案

认证服务领域的人工智慧 TIC 服务在医疗保健行业的规模预计到 2032 年将以复合年增长率大幅扩张。由于服务不断发展,各组织正在采用严格的认证协议来验证人工智慧系统在医疗诊断和患者护理方面的性能,以应对新的挑战并维护监管合规性。

从地区来看,亚太地区医疗保健市场规模的人工智慧TIC 服务预计将在2024 年至2032 年间出现强劲增长,这主要归因于医疗保健支出的不断增加以及诊断、治疗和患者管理人工智慧技术的进步。这些发展为复杂的人工智慧解决方案的整合铺平了道路,以提高该地区医疗保健服务的品质和可靠性。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 供应商格局
    • 供应商
    • TIC 服务提供者
    • 人工智慧技术提供者
    • 配销通路
    • 最终用户
  • 利润率分析
  • 技术与创新格局
  • 专利分析
  • 重要新闻和倡议
  • 监管环境
  • 衝击力
    • 成长动力
      • 医疗保健服务需求不断增长
      • 人工智慧和医疗保健领域的技术进步
      • 医疗保健行业不断提高的监管要求和品质标准
      • 医疗产品的复杂性日益增加
    • 产业陷阱与挑战
      • 复杂的监管环境
      • 初始成本高且投资报酬率不确定
  • 成长潜力分析
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章:市场估计与预测:按服务分类,2021-2032 年

  • 主要动力向:按服务
  • 测试
  • 检查
  • 认证
  • 其他的

第 6 章:市场估计与预测:按类型,2021-2032

  • 主要动向:依类型
  • 内部
  • 外包

第 7 章:市场估计与预测:按应用划分,2021-2032 年

  • 主要动向:按应用
  • 製药和生物技术
  • 临床实验室和诊断
  • 医院和医疗机构
  • 医疗器材

第 8 章:市场估计与预测:按地区,2021-2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 北欧人
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳新银行
    • 东南亚
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • MEA
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • MEA 的其余部分

第 9 章:公司简介

  • AFNOR Group
  • Apave International
  • Applus Services, S.A
  • BSI Group
  • Bureau Veritas
  • Cofrac (Comite Francais d'Accreditation)
  • DEKRA SE
  • DNV GL
  • Emitech Group
  • Eurofins Scientific
  • Expleo
  • Intertek Group PLC
  • LNE (Laboratoire National de Metrologie et d'Essais)
  • Merieux NutriSciences
  • Pharmasafe
  • QualiTest
  • SGS Group
  • TUV Rheinland
  • TUV SUD
  • UL (Underwriters Laboratories)
简介目录
Product Code: 10167

AI Testing, Inspection, and Certification (TIC) Services in Healthcare Market size is anticipated to expand at over 15% CAGR from 2024 to 2032, led by increasing launches along with integration of AI with medical devices.

As innovative devices are making their debut in the healthcare sector, TIC services have grown pivotal for ensuring AI-driven technologies adhere to stringent safety and performance benchmarks. These efforts not only propel advancements in healthcare technology but also prioritize patient well-being. To cite an example, in June 2024, Element Materials Technology unveiled RegNav, its inaugural AI-driven regulatory intelligence platform tailored for medical devices, emphasizing FDA pathways to bolster regulatory efficiency and safety.

The overall market is segregated into service, type, application, and region.

Based on type, the AI TIC services in healthcare market value from the in-house segment is estimated to rise at a notable rate from 2024 to 2032. This is fueled by the escalating demand to uphold stringent standards for AI-driven medical devices. Organizations are undertaking thorough evaluations to affirm the accuracy, safety, and reliability of these technologies for leveraging a controlled environment for meticulous testing and bespoke solutions

AI TIC services in healthcare industry size from the certification service segment is anticipated to expand at a substantial CAGR up to 2032. This expansion is driven by the increasing imperative to guarantee the reliability and safety of AI technologies. Organizations are adopting stringent certification protocols to validate the performance of AI systems in medical diagnostics and patient care on account of evolving services to tackle new challenges and uphold regulatory compliance.

Regionally, the Asia Pacific AI TIC services in healthcare market size is expected to depict robust growth between 2024 and 2032, largely attributed to escalating healthcare expenditures as well as spurring advancements in AI technologies for diagnostics, treatment, and patient management. These developments are paving the way for the integration of sophisticated AI solutions to elevate the quality and reliability of healthcare services in the region.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research design
    • 1.1.1 Research approach
    • 1.1.2 Data collection methods
  • 1.2 Base estimates and calculations
    • 1.2.1 Base year calculation
    • 1.2.2 Key trends for market estimates
  • 1.3 Forecast model
  • 1.4 Primary research and validation
    • 1.4.1 Primary sources
    • 1.4.2 Data mining sources
  • 1.5 Market definitions

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis, 2021-2032

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Supplier landscape
    • 3.2.1 Suppliers
    • 3.2.2 TIC service providers
    • 3.2.3 AI technology providers
    • 3.2.4 Distribution channel
    • 3.2.5 End users
  • 3.3 Profit margin analysis
  • 3.4 Technology and innovation landscape
  • 3.5 Patent analysis
  • 3.6 Key news and initiatives
  • 3.7 Regulatory landscape
  • 3.8 Impact forces
    • 3.8.1 Growth drivers
      • 3.8.1.1 Growing demand for healthcare services
      • 3.8.1.2 Technological advancements in AI and healthcare
      • 3.8.1.3 Increasing regulatory requirements and quality standards in healthcare industry
      • 3.8.1.4 Increasing complexity of medical products
    • 3.8.2 Industry pitfalls and challenges
      • 3.8.2.1 Complex regulatory environment
      • 3.8.2.2 High initial costs and ROI uncertainty
  • 3.9 Growth potential analysis
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Service, 2021-2032 ($ Bn)

  • 5.1 Key trends, by service
  • 5.2 Testing
  • 5.3 Inspection
  • 5.4 Certification
  • 5.5 Others

Chapter 6 Market Estimate and Forecast, By Type, 2021-2032 ($ Bn)

  • 6.1 Key trends, by type
  • 6.2 In-house
  • 6.3 Outsourced

Chapter 7 Market Estimates and Forecast, By Application, 2021-2032 ($ Bn)

  • 7.1 Key trends, by application
  • 7.2 Pharmaceuticals and biotechnology
  • 7.3 Clinical laboratories and diagnostics
  • 7.4 Hospitals and healthcare facilities
  • 7.5 Medical devices

Chapter 8 Market Estimates and Forecast, By Region, 2021-2032 ($ Bn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 UK
    • 8.3.2 Germany
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Russia
    • 8.3.7 Nordics
    • 8.3.8 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 South Korea
    • 8.4.5 ANZ
    • 8.4.6 Southeast Asia
    • 8.4.7 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 MEA
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of MEA

Chapter 9 Company Profiles

  • 9.1 AFNOR Group
  • 9.2 Apave International
  • 9.3 Applus Services, S.A
  • 9.4 BSI Group
  • 9.5 Bureau Veritas
  • 9.6 Cofrac (Comite Francais d'Accreditation)
  • 9.7 DEKRA SE
  • 9.8 DNV GL
  • 9.9 Emitech Group
  • 9.10 Eurofins Scientific
  • 9.11 Expleo
  • 9.12 Intertek Group PLC
  • 9.13 LNE (Laboratoire National de Metrologie et d'Essais)
  • 9.14 Merieux NutriSciences
  • 9.15 Pharmasafe
  • 9.16 QualiTest
  • 9.17 SGS Group
  • 9.18 TUV Rheinland
  • 9.19 TUV SUD
  • 9.20 UL (Underwriters Laboratories)